The role of prolactin receptor in GH signaling in breast cancer cells

Molecular Endocrinology

Volumn 27, Issue 2, 2013, Pages 266-279

  Xu, Jie ^a   Sun, Dongmei ^a   Jiang, Jing ^a   Deng, Luqin ^a   Zhang, Yue ^a   Yu, Hao ^b   Bahl, Deepti ^a   Langenheim, John F ^c   Chen, Wen Y ^c   Fuchs, Serge Y ^d   Frank, Stuart J ^a,b,e  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c CLEMSON UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; JANUS KINASE 2; PROLACTIN RECEPTOR; SHORT HAIRPIN RNA; STAT5 PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GROWTH HORMONE; HUMANS; JANUS KINASE 2; PHOSPHORYLATION; PROLACTIN; RECEPTORS, PROLACTIN; RECEPTORS, SOMATOTROPIN; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR;

EID: 84873032331     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1297     Document Type: Article

References (66)

1. Huising MO, Kruiswijk CP, Flik G 2006 Phylogeny and evolution of class-I helical cytokines. J Endocrinol 189:1-25
2. Teilum K, Hoch JC, Goffin V, Kinet S, Martial JA, Kragelund BB 2005 Solution structure of human prolactin. J Mol Biol 351:810-823
3. Isaksson OG, Edén S, Jansson JO 1985 Mode of action of pituitary growth hormone on target cells. Annu Rev Physiol 47:483-499
4. Kaplan S 1999 Hormonal regulation of growth and metabolic effects of growth hormone. In: Kostyo J, Goodman HM, eds. Handbook of physiology. Chap 5. New York: Oxford University Press
5. Møller N, Jørgensen JO 2009 Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30:152-177
6. Waters MJ, Hoang HN, Fairlie DP, Pelekanos RA, Brown RJ 2006 New insights into growth hormone action. J Mol Endocrinol 36:1-7
7. Goffin V, Binart N, Touraine P, Kelly PA 2002 Prolactin: the new biology of an old hormone. Annu Rev Physiol 64:47-67
8. Rui H 2000 Prolactin. In: Oppenheim JJ, Feldman M, eds. Cytokine reference on-line. London: Academic Press, Harcourt; 267-283
9. Swanson SM, Unterman TG 2002 The growth hormone-deficient Spontaneous Dwarf rat is resistant to chemically induced mammary carcinogenesis. Carcinogenesis 23:977-982
10. Shen Q, Lantvit DD, Lin Q, Li Y, Christov K, Wang Z, Unterman TG, Mehta RG, Swanson SM 2007 Advanced rat mammary cancers are growth hormone dependent. Endocrinology 148:4536-4544
11. Wang Z, Prins GS, Coschigano KT, Kopchick JJ, Green JE, Ray VH, Hedayat S, Christov KT, Unterman TG, Swanson SM 2005 Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse. Endocrinology 146:5188-5196
12. Wang Z, Luque RM, Kineman RD, Ray VH, Christov KT, Lantvit DD, Shirai T, Hedayat S, Unterman TG, Bosland MC, Prins GS, Swanson SM 2008 Disruption of growth hormone signaling retards prostate carcinogenesis in the probasin/TAg rat. Endocrinology 149:1366-1376
13. Clayton PE, Banerjee I, Murray PG, Renehan AG 2011 Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nat Rev Endocrinol 7:11-24
14. Waters MJ, Barclay JL 2007 Does growth hormone drive breast and other cancers? Endocrinology 148:4533-4535
15. Clevenger CV, Furth PA, Hankinson SE, Schuler LA 2003 The role of prolactin in mammary carcinoma. Endocr Rev 24:1-27
16. Goffin V, Touraine P, Pichard C, Bernichtein S, Kelly PA 1999 Should prolactin be reconsidered as a therapeutic target in human breast cancer? Mol Cell Endocrinol 151:79-87
17. Vonderhaar BK 1999 Prolactin involvement in breast cancer. Endocr Relat Cancer 6:389-404
18. Campbell GS, Argetsinger LS, Ihle JN, Kelly PA, Rillema JA, Carter-Su C 1994 Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. Proc Natl Acad Sci USA 91:5232-5236
19. Rui H, Kirken RA, Farrar WL 1994 Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J Biol Chem 269:5364-5368
20. Clevenger CV, Kline JB 2001 Prolactin receptor signal transduction. Lupus 10:706-718
21. Huang Y, Li X, Jiang J, Frank SJ 2006 Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Oncogene 25:7565-7576
22. Boutin JM, Edery M, Shirota M, Jolicoeur C, Lesueur L, Ali S, Gould D, Djiane J, Kelly PA 1989 Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. Mol Endocrinol 3:1455-1461
23. Frank SJ, Gilliland G, Kraft AS, Arnold CS 1994 Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase. Endocrinology 135:2228-2239
24. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN, Carter-Su C 1993 Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237-244
25. VanderKuur JA, Wang X, Zhang L, Campbell GS, Allevato G, Billestrup N, Norstedt G, Carter-Su C 1994 Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase. J Biol Chem 269:21709-21717
26. DaSilva L, Howard OM, Rui H, Kirken RA, Farrar WL 1994 Growth signaling and JAK2 association mediated by membraneproximal cytoplasmic regions of prolactin receptors. J Biol Chem 269:18267-18270
27. Hughes JP, Friesen HG 1985 The nature and regulation of the receptors for pituitary growth hormone. Annu Rev Physiol 47:469-482
28. Cunningham BC, Bass S, Fuh G, Wells JA 1990 Zinc mediation of the binding of human growth hormone to the human prolactin receptor. Science 250:1709-1712
29. Somers W, Ultsch M, De Vos AM, Kossiakoff AA 1994 The X-ray structure of a growth hormone-prolactin receptor complex. Nature 372:478-481
30. Fu YK, Arkins S, Fuh G, Cunningham BC, Wells JA, Fong S, Cronin MJ, Dantzer R, Kelley KW 1992 Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor. J Clin Invest 89:451-457
31. Qazi AM, Tsai-Morris CH, Dufau ML 2006 Ligand-independent homo-and heterodimerization of human prolactin receptor variants: inhibitory action of the short forms by heterodimerization. Mol Endocrinol 20:1912-1923
32. de Vos AM, Ultsch M, Kossiakoff AA 1992 Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306-312
33. Cunningham BC, Ultsch M, De Vos AM, Mulkerrin MG, Clauser KR, Wells JA 1991 Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254:821-825
34. Gent J, van Kerkhof P, Roza M, Bu G, Strous GJ 2002 Ligandindependent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proc Natl Acad Sci USA 99:9858-9863
35. Brown RJ, Adams JJ, Pelekanos RA, Wan Y, McKinstry WJ, Palethorpe K, Seeber RM, Monks TA, Eidne KA, Parker MW, Waters MJ 2005 Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat Struct Mol Biol 12:814-821
36. Yang N, Wang X, Jiang J, Frank SJ 2007 Role of the growth hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation. Mol Endocrinol 21:1642-1655
37. Gadd SL, Clevenger CV 2006 Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications. Mol Endocrinol 20:2734-2746
38. Brooks AJ, Waters MJ 2010 The growth hormone receptor: mechanism of activation and clinical implications. Nat Rev Endocrinol 6:515-525
39. Biener E, Martin C, Daniel N, Frank SJ, Centonze VE, Herman B, Djiane J, Gertler A 2003 Ovine placental lactogen-induced heterodimerization of ovine growth hormone and prolactin receptors in living cells is demonstrated by fluorescence resonance energy transfer microscopy and leads to prolonged phosphorylation of signal transducer and activator of transcription (STAT)1 and STAT3. Endocrinology 144:3532-3540
40. Herman A, Bignon C, Daniel N, Grosclaude J, Gertler A, Djiane J 2000 Functional heterodimerization of prolactin and growth hormone receptors by ovine placental lactogen. J Biol Chem 275:6295-6301
41. Langenheim JF, Chen WY 2009 Development of a novel ligand that activates JAK2/STAT5 signaling through a heterodimer of prolactin receptor and growth hormone receptor. J Recept Signal Transduct Res 29:107-112
42. Xu J, Zhang Y, Berry PA, Jiang J, Lobie PE, Langenheim JF, Chen WY, Frank SJ 2011 Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptorprolactin receptor complex. Mol Endocrinol 25:597-610
43. Yang N, Langenheim JF, Wang X, Jiang J, Chen WY, Frank SJ 2008 Activation of growth hormone receptors by growth hormone and growth hormone antagonist dimers: insights into receptor triggering. Mol Endocrinol 22:978-988
44. Zhang Y, Guan R, Jiang J, Kopchick JJ, Black RA, Baumann G, Frank SJ 2001 Growth hormone (GH)-induced dimerization inhibits phorbol ester-stimulated GH receptor proteolysis. J Biol Chem 276:24565-24573
45. Jiang J, Liang L, Kim SO, Zhang Y, Mandler R, Frank SJ 1998 Growth hormone-dependent tyrosine phosphorylation of a GH receptor-associated high molecular weight protein immunologically related to JAK2. Biochem Biophys Res Commun 253:774-779
46. Jiang J, Wang X, He K, Li X, Chen C, Sayeski PP, Waters MJ, Frank SJ 2004 A conformationally-sensitiveGHR[growth hormone (GH) receptor] antibody: impact on GH signaling and GHR proteolysis. Mol Endocrinol 18:2981-2996
47. Plotnikov A, Varghese B, Tran TH, Liu C, Rui H, Fuchs SY 2009 Impaired turnover of prolactin receptor contributes to transformation of human breast cells. Cancer Res 69:3165-3172
48. Asa SL, Digiovanni R, Jiang J, Ward ML, Loesch K, Yamada S, Sano T, Yoshimoto K, Frank SJ, Ezzat S 2007 A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors. Cancer Res 67:7505-7511
49. Bujalska IJ, Quinkler M, Tomlinson JW, Montague CT, Smith DM, Stewart PM 2006 Expression profiling of 11β-hydroxysteroid dehydrogenase type-1 and glucocorticoid-target genes in subcutaneous and omental human preadipocytes. J Mol Endocrinol 37:327-340
50. Fang F, Flegler AJ, Du P, Lin S, Clevenger CV 2009 Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer. Am J Pathol 174:297-308
51. Fang F, Antico G, Zheng J, Clevenger CV 2008 Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter. BMC Biotechnol 8:11
52. Yi W, Kim SO, Jiang J, Park SH, Kraft AS, Waxman DJ, Frank SJ 1996 Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase. Mol Endocrinol 10:1425-1443
53. He K, Wang X, Jiang J, Guan R, Bernstein KE, Sayeski PP, Frank SJ 2003 Janus kinase 2 determinants for growth hormone receptor association, surface assembly, and signaling. Mol Endocrinol 17:2211-2227
54. He K, Loesch K, Cowan JW, Li X, Deng L, Wang X, Jiang J, Frank SJ 2005 Janus kinase 2 enhances the stability of the mature growth hormone receptor. Endocrinology 146:4755-4765
55. Deng L, He K, Wang X, Yang N, Thangavel C, Jiang J, Fuchs SY, Frank SJ 2007 Determinants of growth hormone receptor downregulation. Mol Endocrinol 21:1537-1551
56. Goffin V, Bernichtein S, Carrière O, Bennett WF, Kopchick JJ, Kelly PA 1999 The human growth hormone antagonist B2036 does not interact with the prolactin receptor. Endocrinology 140:3853-3856
57. Goffin V, Bernichtein S, Touraine P, Kelly PA 2005 Development and potential clinical uses of human prolactin receptor antagonists. Endocr Rev 26:400-422
58. Jiang J, Wan Y, Wang X, Xu J, Harris JM, Lobie PE, Zhang Y, Zinn KR, Waters MJ, Frank SJ 2011 Inhibitory GH receptor extracellular domain monoclonal antibodies: three-dimensional epitope mapping. Endocrinology 152:4777-4788
59. Deng L, Jiang J, Frank SJ 2012 Growth hormone-induced JAK2 signaling and GH receptor down-regulation: role of GH receptor intracellular domain tyrosine residues. Endocrinology 153:2311-2322
60. Ionescu M, Frohman LA 2006 Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab 91:4792-4797
61. Tannenbaum GS, Martin JB 1976 Evidence for an endogenous ultradian rhythm governing growth hormone secretion in the rat. Endocrinology 98:562-570
62. MacLeod JN, Pampori NA, Shapiro BH 1991 Sex differences in the ultradian pattern of plasma growth hormone concentrations in mice. J Endocrinol 131:395-399
63. Utama FE, Tran TH, Ryder A, LeBaron MJ, Parlow AF, Rui H 2009 Insensitivity of human prolactin receptors to nonhuman prolactins: relevance for experimental modeling of prolactin receptorexpressing human cells. Endocrinology 150:1782-1790
64. He K, Loesch K, Cowan JW, Li X, Deng L, Wang X, Jiang J, Frank SJ 2005 JAK2 enhances the stability of the mature GH receptor. Endocrinology 145:4755-4765
65. Loesch K, Deng L, Wang X, He K, Jiang J, Frank SJ 2007 Endoplasmic reticulum-associated degradation of growth hormone receptor in Janus kinase 2-deficient cells. Endocrinology 148:5955-5965
66. Piazza TM, Lu JC, Carver KC, Schuler LA 2009 SRC family kinases accelerate prolactin receptor internalization, modulating trafficking and signaling in breast cancer cells. Mol Endocrinol 23:202-212